REGISTER OF INTERESTS SIGN guideline 154: Pharmacological management of glycaemic control in people with type 2 diabetes Published: 29 November 2017
|
|
|
- Maximilian McCormick
- 5 years ago
- Views:
Transcription
1 CHAIR John Petrie, Professor of Diabetic Medicine Financial Non-financial Non-personal Last updated Specific Non-Specific Specific Non- Specific Professor of Diabetic Medicine, University of Glasgow Academic. Honorary Consultant Physician/ Diabetologist NHS GGC Healthcare. Applied Clinical Intelligence Adjudication Committee for Boehringer Ingelheim trials of empagliflozin in type 1 diabetes. Diabetologia European diabetes journal (advisory board). Clinical Trial Committees (steering/adjudication /Glycemia) Novo Nordisk, Sanofi, Shareholder Lecht Ski Company. Trustee of Novo Nordisk UK Research Foundation ( ). Chair Complications Clinical Studies Group, Diabetes UK ( ). None Donation of medication for REMOVAL clinical trial (metformin in type 1 diabetes) of which I am Chief Investigator Merck KGaA (Germany). Donation of reading services for endothelial function in REMOVAL trial (ENDOPAT) Itamar Medical (Israel). Research Fellowship for Rachel Livingstone ( ) Novo Nordisk UK Research Foundation. Support for annual meeting of European Group for the study of Insulin Resistance Novo Nordisk. RISC study 12 year follow-up grant to Action Agreed to not be allocated to questions on liraglutide or lixisenatide due to work on LEADER and ELIXA trials. 1
2 Roche/Genentech, Quintiles/Janssen approx. once monthly. Including membership of LEADER trial Global Expert Panel ( , Novo Nordisk) and ELIXA trial UK coordinator ( , Sanofi). These are the recent cardiovascular outcome trials with liraglutide and lixisenatide. University of Pisa ( ) Janssen Pharmaceuticals. Grantholder: investigator-sponsored trial of empagliflozin in patients with diabetes and heart failure, Chief Investigator N Sattar ( ) Boehringer-Ingelheim. Consultancy Novo Nordisk, Servier, Lilly approx. once every two months. Speaker Novo Nordisk, Lilly, Boehringer approx. once every two months. Now adjudication committee membership May 2
3 2017 Boehringer EMPEROR trials. Pfizer. GUIDELINE DEVELOPMENT GROUP MEMBER Allan Cairns, (Patient Representative) None I am retired, no employer. None None None None No action Samantha Carmichael, (Lead Pharmacist) Lead Pharmacist Clinical Trials/R&D NHS Greater Glasgow and Clyde. Samantha Carmichael selfemployed locum pharmacist. Travel and accommodation paid for participation in international meetings regarding clinical trials site perspectives Fisher Clinical Services, 2 3 times per year. None None None No action Chair of clinical Trials Specialist Interest Group for pharmacists & technicians in Scotland. Member of The National Pharmacy 3
4 Gemma Currie, (Clinical Lecturer) Andrea Llano, (ST5 in Clinical Pharmacology and Therapeutics) David McGrane, (Consultant Physician) Clinical Lecturer, University of Glasgow academic/clinical ST5 in Clinical Pharmacology and Therapeutics, Department of Diabetes, Endocrinology & Clinical Pharmacology, Glasgow Royal Infirmary, Glasgow. Consultant Physician, GGC Health Board Provision of clinical expertise and management of patients within my Clinical Trials Advisory Group (Royal Pharmaceutical Society Network). Member of the Guild of Hospital Pharmacists. None None None None No action None None None None No action None None Member, Scottish South Asian Health Foundation None No clear conflict with individual products linked to guideline therefore no action. 4
5 Gerard McKay, (Honorary Clinical Associate Professor) role as a Consultant Physician. Northview Consultancy Ltd provision of advice and consultancy to pharmaceutical companies once monthly. Advisory work, speaker at meetings, providing education AZ, Boehringer Ingelheim, Janssen, Lilly, MSD, NAPP, Novo Novodisk, Sanofi, Takeda, Sunovion on average once or twice monthly in total. Consultant Physician NHS GG&C, Glasgow Royal Infirmary health care provision including management of patients with diabetes. None None None None Declaration of potential conflict (SGLT2 inhibitors). Discussion with all group members and agreement to continued work on this question in partnership with second group 5
6 G McKay Medical Advisory Ltd medical advisory, consultancy work (intermittently for companies including Novo Nordisk, BoehringerIngleheim, Sanofi, AZ, MSD, and Eli Lilly) This includes advising on a submission to SMC (Boehringer Ingleheim). self and partner. member. Independent review of pivotal decisions by HIS researcher with follow up to resolve queries revealed no anomalous decision. May Millward, (Patient Representative) Project Officer, Scottish Mediation Network Professional body for accredited mediators in Scotland. None Chair of West Lothian Diabetes Scotland Group. None None No action Chris Schofield, (Consultant Physician) Consultant Physician, NHS Tayside. Fee for travel, accommodation & conference Alexion Pharmaceuticals, Single episode. None Site PI for Alexion Pharmaceuticals database for the study of hereditary hypohosphatatsia None None No clear conflict with individual products linked to guideline therefore no action. 6
Membership of Spondyloarthritis guideline Committee
Membership of Committee The Committee will operate as an advisory Committee to NICE s Board developing clinical guideline on Spondyloarthritis The terms of reference and standing orders for the Committee
Diabetes Update: Keeping patients safe. Victoria Ruszala MFRPSII North Bristol NHS Trust
Diabetes Update: Keeping patients safe Victoria Ruszala MFRPSII North Bristol NHS Trust Declaration of Interests I have received funding from the following companies for providing education sessions, attending
Current Updates & Challenges In Managing Diabetes in CVD
Current Updates & Challenges In Managing Diabetes in CVD Preventive Cardiovascular Conference 2016 Instituit Jantung Negara 12 th November 2016 Nor Azmi Kamaruddin Diabetes Clinic Department of Medicine
Professor of Medicine (Diabetes), ABMU Health Board & Swansea University
SIGN Diabetes Consultation COMMENTS RECEIVED FROM EXTERNAL REFEREES AND OTHERS All reviewers submitted declarations of interests which were viewed prior to the addressing of comments. Please note that
Membership of cirrhosis guideline Committee
Membership of cirrhosis guideline Committee The Committee will operate as an advisory Committee to NICE s Board, developing a guideline on cirrhosis. The terms of reference and standing orders for the
Appendix A: Guideline development group membership and declarations of interest
Appendix A: Guideline development group membership and declarations of A.1 Guideline development group Damien Longson (Guideline Chair) Consultant Liaison Psychiatrist, Manchester Mental Health and Social
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES PUBLISHED AUGUST 2016 There is growing distrust of pharma in light of several recent and dramatic
Du gusts is megl che one. Edoardo Mannucci
Du gusts is megl che one Edoardo Mannucci Conflitti di interessi Negli ultimi due anni, E. Mannucci ha ricevuto compensi per relazioni e/o consulenze da: Abbott, AstraZeneca, Boehringer Ingelheim, Eli
CROSS-PARTY GROUP REGISTRATION FORM
CROSS-PARTY GROUP REGISTRATION FORM NAME OF CROSS-PARTY GROUP Cross-Party Group on Cancer PURPOSE OF THE GROUP AND PROPOSED DISCUSSION TOPICS 1. Please state the purpose of the Group. 2. Please also provide
NHS Greater Glasgow & Clyde. Managed Clinical Network for Diabetes. Annual Report
NHS Greater Glasgow & Clyde Managed Clinical Network for Diabetes Annual Report 2009 / 2010 1. Introduction This annual report of the NHS Greater Glasgow and Clyde (NHS GGC) Managed Clinical Network (MCN)
Type 2 Diabetes in Practice. An Expert Commentary with Farhad Zangeneh, MD, FACP, FACE A Clinical Context Report
Type 2 Diabetes in Practice An Expert Commentary with Farhad Zangeneh, MD, FACP, FACE A Clinical Context Report Clinical Context: Type 2 Diabetes in Practice Expert Commentary Jointly Sponsored by: and
Gli inibitori di SGLT-2 possono essere impiegati nel diabete di tipo 1?
Impatto degli inibitori di SGLT-2 nei pazienti con diabete di tipo 2 Corso SID Hotel Michelangelo, Milano. 26 Giugno 2018 Gli inibitori di SGLT-2 possono essere impiegati nel diabete di tipo 1? Emanuele
A Clinical Context Report
Type 2 Diabetes in Practice An Expert Commentary with Silvio E. Inzucchi, MD A Clinical Context Report Clinical Context: Type 2 Diabetes in Practice Expert Commentary Jointly Sponsored by: and Clinical
HEALTH AND SPORT COMMITTEE AGENDA. 14th Meeting, 2018 (Session 5) Tuesday 1 May 2018
HS/S5/18/14/A HEALTH AND SPORT COMMITTEE AGENDA 14th Meeting, 2018 (Session 5) Tuesday 1 May 2018 The Committee will meet at 10.00 am in the James Clerk Maxwell Room (CR4). 1. Scottish Health Council Review:
Canadian Stroke Best Practice Recommendations STROKE PREVENTION WRITING GROUP 2017:
Canadian Stroke Best Practice Recommendations STROKE PREVENTION WRITING GROUP 2017: NAME PROFESSIONAL ROLE LOCATION DECLARED CONFLICTS OF INTEREST Wein, Theodore Gladstone, David Côté, Robert Berlingieri,
CANCER IN SCOTLAND: ACTION FOR CHANGE The structure, functions and working relationships of Regional Cancer Advisory Groups
CANCER IN SCOTLAND: ACTION FOR CHANGE The structure, functions and working relationships of Regional Cancer Advisory Groups Introduction/Background 1. Our National Health: A Plan for action, a plan for
Navigating the New Options for the Management of Type 2 Diabetes
Navigating the New Options for the Management of Type 2 Diabetes Clinical Associate Professor Mark Kennedy Department of General Practice, University of Melbourne Chair, Primary Care Diabetes Society of
Membership of Asthma management guideline Committee
Principle to document the membership of a guideline Committee and DOIs (to be uploaded as soon as the Committee is appointed; and updated at Scope Consultation; Guideline Consultation; and final publication)
Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation
Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation Consensus Statement ~ October 2011 Contents 1 About 3 2 Introduction 5 3 Development of the consensus
Industry Relationships and Institutional Affiliations
Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated daily statin: results from the ODYSSEY COMBO II study Christopher
TABLE OF CONTENTS 1 Table of Contents 2 Introduction 3 Key Marketed Products
TABLE OF CONTENTS 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Epidemiology 2.2 Symptoms 2.3 Etiology 2.4 Pathophysiology 2.5 Co-morbidities and Complications 2.6 Classification
Update on Cardiovascular Outcome Trials in Diabetes Jay S. Skyler, MD, MACP
Update on Cardiovascular Outcome Trials in Diabetes Jay S. Skyler, MD, MACP Division of Endocrinology, Diabetes, and Metabolism and Diabetes Research InsAtute University of Miami Miller School of Medicine
Target Audience. approach this patient case scenario, including identifying an
Activity Overview In this case-based webcast, meet LaWanda, a 57-year-old woman with type 2 diabetes. Her glycated hemoglobin (HbA1C) is 8.4%, she is currently taking basal insulin and fast-acting insulin,
Activity Report April 2012 to March 2013
North, South East and West of Scotland Cancer Networks Brain/Central Nervous System Tumours National Managed Clinical Network Activity Report April 2012 to March 2013 Professor Roy Rampling Emeritus Professor
Patient and Physician Perspectives on Administration of the PCSK9 Monoclonal Antibody Alirocumab, an Injectable Medication to Lower LDL-C Levels
Patient and Physician Perspectives on Administration of the PCSK9 Monoclonal Antibody Alirocumab, an Injectable Medication to Lower LDL-C Levels Bertrand Cariou, 1 Maja Bujas-Bobanovic, 2 Michael J Louie,
Membership of Heavy Menstrual Bleeding (update) guideline Committee
membership list Heavy Menstrual Bleeding (update) guideline Membership of Heavy Menstrual Bleeding (update) guideline The will operate as an advisory to NICE s Board, developing a guideline on Post- The
Very Practical Tips for Managing Type 2 Diabetes
Very Practical Tips for Managing Type 2 Diabetes Jean-François Yale, MD, FRCPC McGill University Health Centre, Montreal, Canada Jean-francois.yale@mcgill.ca www.dryale.ca OBJECTIVES DISCLOSURES The participant
British Fertility Society. Clinical guidelines
Guidance producer: British Fertility Society Guidance Product: Clinical guidelines Date: 13 January 2011 Final Accreditation Report Contents Introduction... 3 Accreditation recommendation... 3 Reapplication
SHARP ANNUAL SCIENTIFIC MEETING
HILTON DUNKELD HOUSE HOTEL 19 th /20 th NOVEMBER Organising Committee Professor Tom MacDonald Dr Alan Begg Secretariat Miss Victoria Kirkwood THURSDAY 19 th NOVEMBER PROGRAMME 08.15 Registration Opens
Current and future market dynamics overview
OVERVIEW Catalyst Summary EXECUTIVE SUMMARY Strategic scoping and focus Datamonitor key findings Related reports MARKET DEFINITION Published diabetes reports Market definition for antidiabetic drugs Forecast
An eye for the big picture
An eye for the big picture When the Boehringer Ingelheim Science Department was founded 100 years ago, future Nobel Prize winner Heinrich Wieland ensured that this was done in a future-oriented way. Today,
Terapia con agonisti GLP1 e outcome cardiovascolare. Edoardo Mannucci
Terapia con agonisti GLP e outcome cardiovascolare Edoardo Mannucci Conflitti di interessi Negli ultimi due anni, E. Mannucci ha ricevuto compensi per relazioni e/o consulenze da: Abbott, AstraZeneca,
BSGE Council Member Declaration of Interests 2017
BSGE Council Member Declaration of Interests 2017 Name Kirana Arambage BSGE Role Chair- Awards & Bursaries DoI signed on 30 Aug 2017 Dominic Byrne President 18 Aug 2017 Any office or position held in NHS
Dear Colleague. DL (2017) June Additional Funding for CGMs and Adult Insulin Pumps Summary
The Scottish Government Healthcare Quality & Improvement Directorate DG Health & Social Care Dear Colleague Additional Funding for CGMs and Adult Insulin Pumps 2017-18 Summary On 7 December 2016, the First
17 January 2018 Mary Maclean 50 West Nile Street Glasgow G1 2NP
17 January 2018 Mary Maclean mary.maclean4@nhs.net 50 West Nile Street Glasgow G1 2NP Dear Colleague Abiraterone in newly diagnosed hormone naive prostate cancer Abiraterone is currently licensed and accepted
Deaths Hospitalizations Company. Takeda Pharmaceuticals. Takeda Pharmaceuticals. Takeda Pharmaceuticals. Janssen Pharmaceuticals
Takeaways: Diabetes Drug Investigation From: BSardi@aol.com Sent: Mon, Dec 22, 2014 at 10:51 am To: Cc: gemcap2@reagan.com martie.whittekin@verizon.net, katjames008@gmail.com clip_image002.jpg (64.5 KB)
Update on Diabetes Cardiovascular Outcome Trials
Update on Diabetes Cardiovascular Outcome Trials Jay S. Skyler, MD, MACP Division of Endocrinology, Diabetes, and Metabolism and Diabetes Research Institute University of Miami Miller School of Medicine
STEP THERAPY CRITERIA
CATEGORY DRUG CLASS BRAND NAME (generic) STEP THERAPY CRITERIA AMYLIN ANALOG: SYMLIN/SYMLINPEN (pramlintide acetate) ANTIDIABETIC AGENTS GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST (GLP-1): ADLYXIN (lixisenatide)
Changing Treatment Paradigms with Immunotherapy and Targeted Therapy in Advanced Non-Small-Cell Lung Cancer and Head & Neck Cancer
Saturday, October 27, 2018 7:00 AM - 3:45 PM Changing Treatment Paradigms with Immunotherapy and Targeted Therapy in Advanced Non-Small-Cell Lung Cancer and Head & Neck Cancer Program Director John V.
A minute of the PASS Monitoring and Evaluation Advisory Group. held on Friday 30 th October in Meeting Room 4, Delta House
Patient Advice and Support Service (PASS): Monitoring and Evaluation Advisory Group A minute of the PASS Monitoring and Evaluation Advisory Group held on Friday 30 th October 2015 in Meeting Room 4, Delta
Activity Report April 2013 March 2014
North, South East and West of Scotland Cancer Networks HepatoPancreatoBiliary Cancers National Managed Clinical Network Activity Report April 2013 March 2014 Mr Colin McKay Consultant Surgeon NMCN Clinical
BRIAN MOSES, MD, FRCPC (INTERNAL MEDICINE) CHIEF OF MEDICINE, SOUTH WEST HEALTH
Insulin Initiation BRIAN MOSES, MD, FRCPC (INTERNAL MEDICINE) CHIEF OF MEDICINE, SOUTH WEST HEALTH Disclosures In the past 12 months, I have received speakers honoraria from AstraZeneca, Boehringer Ingelheim,
La lezione dei trials di safety cardiovascolare. Edoardo Mannucci
La lezione dei trials di safety cardiovascolare Edoardo Mannucci Conflitti di interessi Negli ultimi due anni, E. Mannucci ha ricevuto compensi per relazioni e/o consulenze da: Abbott, AstraZeneca, Boehringer
Activity Report April 2014 March 2015
North, South East and West of Scotland Cancer Networks Brain/Central Nervous System Tumours National Managed Clinical Network Activity Report April 2014 March 2015 Dr Avinash Kanodia Consultant Radiologist
Area 062 Gyle Square 1 South Gyle Crescent Edinburgh EH12 9EB Telephone: Fax:
National Services Division Minutes Area 062 Gyle Square 1 South Gyle Crescent Edinburgh EH12 9EB Telephone: 0131 275 7546 Fax: 0131 275 7614 www.nsd.scot.nhs.uk www.sdsd.scot.nhs.uk Scottish Differences
Constitution, Terms of Reference and Standing Orders
ASSOCIATION FOR RESPIRATORY TECHNOLOGY & PHYSIOLOGY ARTP SLEEP APNOEA CONSORTIUM (ARTP SAC) FINAL VERSION JULY 2008 Constitution, Terms of Reference and Standing Orders 1. INTRODUCTION 1.1 Since 2004 the
Cronfa - Swansea University Open Access Repository
Cronfa - Swansea University Open Access Repository This is an author produced version of a paper published in: The Lancet Diabetes & Endocrinology Cronfa URL for this paper: http://cronfa.swan.ac.uk/record/cronfa33201
Patient and Public Reference Group for Medicines ADTC Sub-group NHS Tayside 17 th February 2015
Patient and Public Reference Group for Medicines ADTC Sub-group NHS Tayside 17 th February 2015 Claire James, Senior Pharmacist Clinical Effectiveness, Ninewells Hospital Aims To increase awareness and
Ms Margaret Mitchell MSP Convener, Justice Committee Room T2.60 The Scottish Parliament Edinburgh EH99 1SP 19 August 2016
Independent Prison Monitoring Advisory Group Saughton House, Y1 Spur, Broomhouse Drive, Edinburgh EH11 3XD Telephone No. 0131 244 1990 Ms Margaret Mitchell MSP Convener, Justice Committee Room T2.60 The
Ovarian Cancer Guideline. Association of Chartered Physiotherapists in Oncology and Palliative Care
Ovarian Cancer Guideline Stakeholder List: A Little Wish Abbott GmbH & Co KG Abbott Laboratories Limited Aberdeen Royal Infirmary Airedale NHS Foundation Trust Almac Diagnostics Anglia cancer network Arden
Total Payment for sponsored attendances by Healthcare Professionals: 182,677 ( 153,923 in 2013)
Gilead Sciences Ltd. 280 High Holborn London WC1V 7EE 31st March 2015 Relationships with Healthcare Professionals in the United Kingdom Gilead Sciences makes payments to Healthcare Professionals for consultancy
NHS Smoking Cessation Service Statistics (Scotland) 1 st January to 31 st December 2006
NHS Smoking Cessation Service Statistics (Scotland) 1 st January to 31 st December 2006 1. Introduction This report provides an analysis of NHS smoking cessation services uptake and outcomes during the
Prevention of complications: are we winning or losing the battle. Naveed Sattar Professor of Metabolic Medicine
Prevention of complications: are we winning or losing the battle Naveed Sattar Professor of Metabolic Medicine Duality of Interest Declaration Consultant or speaker for: Amgen, AstraZeneca, Boehringer
Activity Report April 2012 March 2013
North, South East and West of Scotland Cancer Networks HepatoPancreatoBiliary Cancers National Managed Clinical Network Activity Report April 2012 March 2013 Mr Colin McKay Consultant Surgeon NMCN Clinical
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review Review of TA151 Continuous subcutaneous insulin infusion for the treatment
Appendix K Declarations of Interests
Appendix K Declarations of Interests Ms Theresa Shaw - Chair, Guideline Development Group Chief Executive, Foundation of Nursing Studies (FoNS), London Funding for the 'Developing Practice for Healthy
West of Scotland Cancer Network. Transforming Care After Treatment (TCAT) Implementation Steering Group. Terms of Reference
West of Scotland Cancer Network Transforming Care After Treatment (TCAT) Implementation Steering Group Terms of Reference CONTENTS 1. Purpose 3 2. Background 3 3. Objectives 3 4. Scope 3 5. Constraints
Diabetes and Heart Failure: The Role of SGLT2 Inhibitors
22 nd Annual Heart Failure 2018 Symposium Diabetes and Heart Failure: The Role of SGLT2 Inhibitors Gregg C. Fonarow, MD, FACC, FAHA, FHFSA Elliot Corday Professor of Cardiovascular Medicine UCLA Division
Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn
Letter Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, openlabel study J. Rosenstock 1,2,
Ways to talk about Diabetes Meds Tom Ransom Div. Endocrinology, Capital Health April 5, 2018
Ways to talk about Diabetes Meds Tom Ransom Div. Endocrinology, Capital Health April 5, 2018 Disclosures Faculty/Presenter: Tom Ransom Relationships with commercial interests: Grants/research support:
Post MI LVSD Teach and Treat
Post MI LVSD Teach and Treat Scottish Heart Failure Nurse Forum GJNH, Sept 2017 Dr Clare Murphy Consultant Cardiologist Clinical Lead, National Heart Failure Hub Background to Post MI LVSD Teach and Treat
Royal College of Radiologists (RCR) Referral guidelines. Final Accreditation Report. Guidance producer: Guidance product: Date: 29 June 2010
Guidance producer: Royal College of Radiologists (RCR) Guidance product: Referral guidelines Date: 29 June 2010 Final Accreditation Report Contents Introduction... 3 Accreditation recommendation... 3 Implementation...
Glucose Control and Prevention of Cardiovascular Disease
Glucose Control and Prevention of Cardiovascular Disease Dr Peter A Senior BMedSci MBBS PhD FRCP(E) Associate Professor, Director Division of Endocrinology, University of Alberta Diabetes Update+, March
Insulin Pumps and Glucose Sensors in Diabetes Management
Diabetes Update+ 2014 Congress Whistler, British Columbia Friday March 21, 2014ǀ 8:15 8:45 am Insulin Pumps and Glucose Sensors in Diabetes Management Bruce A Perkins MD MPH Division of Endocrinology Associate
We are currently recruiting new members to advisory groups for the following research programmes:
Information for applicants to join NIHR as an advisory group member: HTA Programme Topic Identification, Development and Evaluation (TIDE) panel Chairs 1. Background information The goal of the National
Preventing Serious Health Consequences of Type 2 Diabetes
Preventing Serious Health Consequences of Type 2 Diabetes The Evidence Hertzel C. Gerstein MD MSc FRCPC Professor and Population Health Institute Chair in Diabetes Research McMaster University and Hamilton
URGENT UPDATED ADVICE ON DOSAGE OF OSELTAMIVIR IN CHILDREN UNDER ONE YEAR OF AGE WITH SWINE FLU
Primary and Community Care Directorate Pharmacy Division T: 0131-244 2518 F: 0131-244 2375 E: bill.scott@scotland.gsi.gov.uk 25 September 2009 abcdefghijklmnopqrstu = 1. Medical Directors NHS Boards 2.
Programme. Scottish Psychiatry - setting the scene, addiction and transplant psychiatry Chaired by Dr Bruce Ritson OBE. MD. FRCPsych. FRCPE.
The Royal College of Psychiatrists in Scotland 20 th Anniversary of the Office in Scotland Thursday 2 nd and Friday 3 rd October 2014 George Hotel, Edinburgh, EH2 2PB Programme THURSDAY 2 nd OCTOBER 2014
Improving the detection of myocardial infarction in women
Improving the detection of myocardial infarction in women British Cardiac Society Listening to the Female Voice 4 th June 2014 anoopsshah@gmail.com Dr Anoop Shah BHF Centre for Cardiovascular Sciences
Morag Dorward is chair of the RCSLT Board of Trustees. Rebecca Richards is the director of NHS Wales Finance Academy
Royal College of Speech and Language Therapists RCSLT Study Day and AGM Speech and language therapy: Showing your worth through value-based healthcare #RCSLTStudyDay2018 Biographies Thursday 4 October
FARXIGA (dapagliflozin) Jardiance (empagliflozin) tablets. Synjardy (empagliflozin and metformin hydrochloride) tablets. GLUCOPHAGE* (metformin)
Type 2 Medications Drug Class How It Works Brand and Generic Names Manufacturers Usual Starting Dose The kidneys filter sugar and either absorb it back into your body for energy or remove it through your
National Group for Volunteering in NHS Scotland
National Group for Volunteering in NHS Scotland Minutes of the meeting held on Tuesday 23 August 2016 at Delta House, West Nile Street, Glasgow Present Neil Galbraith Rob Coward Sandie Dickson Marion Findlay
DAFNE Sponsorship Opportunities
DAFNE Sponsorship Opportunities 2016-2017 Background to the DAFNE programme DAFNE (Dose Adjustment For Normal Eating) is an evidenced skills-based structured education programme in intensive insulin therapy
Gli endpoint micro-vascolari nei trial di outcome cardiovascolare
Gli endpoint micro-vascolari nei trial di outcome cardiovascolare Giorgio Sesti University Magna Graecia of Catanzaro ITALY Potenziali conflitti di interesse Il Prof Giorgio Sesti dichiara di aver ricevuto
Neurological Alliance of Scotland. Executive Meeting Tuesday 9 th September 2014 MND Offices, Firhill, Glasgow at am
Neurological Alliance of Scotland Executive Meeting Tuesday 9 th September 2014 MND Offices, Firhill, Glasgow at 10.30 am Present:- Craig Stockton MND (Chair) Tanith Muller Parkinson UK (Vice Chair) Anissa
This article is a CME/CE certified activity. To earn credit for this activity visit:
Novel Perspectives on Type 2 Diabetes: Traditional and Emerging Therapies and the Potential Role of the Kidneys This article is a CME/CE certified activity. To earn credit for this activity visit: www.medscape.org/lecture/t2dm-therapies
Membership of Lyme disease Guideline Committee
Membership of Lyme disease Guideline Committee The Committee will operate as an advisory Committee to NICE s Board, developing a guideline on Lyme disease. The terms of reference and standing orders for
Yellow Card Centre Scotland Centre for Adverse Reactions to Drugs (Scotland)
Yellow Card Centre Scotland Centre for Adverse Reactions to Drugs (Scotland) Minutes from Advisory Group Meeting Thursday 13 September at 2.30pm in Seminar Room 4 (FU223), Chancellor s Building, RIE Present:
NAME CTS AFFILIATION DISCLOSURE UPDATED
NAME CTS AFFILIATION DISCLOSURE UPDATED Darcy Marciniuk (Chair) and Canadian and Canadian COPD Alliance Consultant Fee, Speaker s Bureau, Advisory Committee: AstraZeneca, Boehringer-Ingelheim, Canadian
Why is Earlier and More Aggressive Treatment of T2 Diabetes Better?
Blood glucose (mmol/l) Why is Earlier and More Aggressive Treatment of T2 Diabetes Better? Disclosures Dr Kennedy has provided CME, been on advisory boards or received travel or conference support from:
EUROPEAN HEART RHYTHM ASSOCIATION A Registered Branch of the ESC
Application for the following position in the EHRA Board: (please specify) SECRETARY 1. Your Identity Title: Professor Dr., PhD, FESC, FACC Family Name(s): HATALA First Name(s): ROBERT Birth Date: 21 st
Consultation on the role of the Scottish Health Council
Consultation on the role of the Scottish Health Council What you told us and what we will do next March 2018 Healthcare Improvement Scotland 2018 Published March 2018 This document is licensed under the
Powys teaching Health Board. Local Healthcare Professionals Forum. Terms of Reference - DRAFT
1. Purpose Powys teaching Health Board Local Healthcare Professionals Forum Terms of Reference - DRAFT As an Advisory Group of Powys teaching Health Board the Forum is accountable to the Health Board and
Prostate Cancer Priority Setting Partnership. PROTOCOL June 2009
Prostate Cancer Priority Setting Partnership PROTOCOL June 2009 Purpose The purpose of this protocol is to set out the aims, objectives and commitments of the Prostate Cancer Priority Setting Partnership
Managing diabetes. Editors. Jiten Vora Royal Liverpool University Hospital Liverpool, UK. Marc Evans University Hospital of Llandough Cardiff, UK
Managing diabetes Managing diabetes Editors Jiten Vora Royal Liverpool University Hospital Liverpool, UK Marc Evans University Hospital of Llandough Cardiff, UK With contributions from Rupa Ahluwalia Royal
A Guide to the Scottish Medicines Consortium
A Guide to the Scottish Medicines Consortium Providing advice about newly licensed medicines www.scottishmedicines.org About the Scottish Medicines Consortium The Scottish Medicines Consortium (SMC) provides
NHS FORTH VALLEY LOCAL ENHANCED SERVICE (2010) General Practitioner Prescribing Service (GPPS) Opiate Assisted Treatment Service Specification
NHS FORTH VALLEY LOCAL ENHANCED SERVICE (2010) Rationale General Practitioner Prescribing Service (GPPS) Opiate Assisted Treatment Service Specification Aims It is the responsibility of general practitioners
British Psychological Society response to the Scottish Parliament. Healthcare in prisons
response to the Scottish Parliament About the Society The, incorporated by Royal Charter, is the learned and professional body for psychologists in the United Kingdom. We are a registered charity with
Name Title Interests Declared Gifts and Hospitality Dr Andrew Parson
REGISTER OF INTERESTS - BROMLEY CCG GOVERNING BODY JANUARY 2018 ENCLOSURE 1 MEMBERS (STATUTORY) Name Title Interests Declared Gifts and Hospitality Dr Andrew Parson Clinical Chair Chislehurst Medical Practice
THINC-it: what is it? John Harrison Alzheimer Center, VU University Medical Center, West London Mental Health Trust, Metis Cognition Ltd
THINC-it: what is it? John Harrison Alzheimer Center, VU University Medical Center, West London Mental Health Trust, Metis Cognition Ltd Disclosures Associate Professor in the Alzheimer Center at the VU
Wednesday 23rd September HEAT TARGETS: NETWORK EVENT Fall and fracture prevention
Wednesday 23rd September 2009 HEAT TARGETS: NETWORK EVENT Fall and fracture prevention Ann Murray Falls Programme Manager Practice Development Unit NHS Quality Improvement Scotland Prevalence of falls
NHS GG&C Introduction of Freestyle Libre flash glucose monitoring system
NHS GG&C Introduction of Freestyle Libre flash glucose monitoring system The Freestyle Libre flash glucose monitoring system is a sensor based, factory-calibrated system that measures interstitial fluid
Novo Nordisk Pharma AG Methodology Note - reporting year 2016 ( Methodology )
Novo Nordisk Pharma AG Methodology Note - reporting year 2016 ( Methodology ) Table of contents Preamble... 0 1. General Summary... 1 2. Terminology and Definitions... 2 3. Change log... 8 Preamble Novo
Dr Barry D Vallance. Where does palliative care for patients with heart failure fit into the Scottish agenda for heart disease
Where does palliative care for patients with heart failure fit into the Scottish agenda for heart disease Advanced Heart Failure Symposium RCPSG 22 nd November 2012 Dr Barry D Vallance Lead Clinician for
Kenneth Gordon, 1 Kim A. Papp, 2 Kara Creamer Rice, 3 Mona Trivedi, 3 David H. Collier, 3 Greg Kricorian 3
American Academy of Dermatology 75 th Annual Meeting, Orlando, FL; March 3 7, 2017 Poster 4563 Novel Evaluation of Psoriasis Area and Severity Index (PASI) Data: Distribution of PASI Improvements in a
SPECIALTY TRAINEE IN ORTHODONTICS GLASGOW DENTAL HOSPITAL AND SCHOOL AND INVERCLYDE ROYAL HOSPITAL, GREENOCK
SPECIALTY TRAINEE IN ORTHODONTICS GLASGOW DENTAL HOSPITAL AND SCHOOL AND INVERCLYDE ROYAL HOSPITAL, GREENOCK Job Profile SPECIALTY TRAINING POST IN ORTHODONTICS JOB PROFILE One full time specialty training
Cancer Support Scotland AGM & Speakers Morning
Cancer Support Scotland AGM & Speakers Morning Monday 19th September 2016 Cancer Support Scotland AGM & Speakers Morning 2016 This half day conference will focus on the needs of people affected by cancer
American Association for Cardiovascular and Pulmonary Rehabilitation (AACVPR)
Organizations Supporting the Preventive Health Savings Act Academy of Nutrition and Dietetics ACT The App Association Aetna Alliance for Aging Research Allscripts Alzheimer s Association Alzheimer s Impact